Trial eligibility, treatment patterns and outcome for venetoclax-based therapy in AML: a prospective cohort study.
Wolach O, Levi I, Nachmias B, Tavor S, Amitai I, Ofran Y, Ganzel C, Zuckerman T, Okasha D, Hellmann I, Tadmor T, Dally N, Canaani J, Stemer G, Grunspan M, Berger AJ, Frankel N, Berelovich J, Bleterman A, Barak M, Cohen R, Moshe Y.
Wolach O, et al. Among authors: berger aj.
Blood Adv. 2024 Dec 5:bloodadvances.2024014014. doi: 10.1182/bloodadvances.2024014014. Online ahead of print.
Blood Adv. 2024.
PMID: 39637307